Acetylation is pivotal in p53 activation, and the suppression of fatty acid binding protein 4 (FABP4) activates SIRT1, which in turn deacetylates p53-STAT, thereby inhibiting pyroptosis and mitigating type 2 diabetes [28]. The gene discussed is TP53; the disease is type 2 diabetes mellitus.